Valuation: Steris PLC

Market Cap 20.33B 18.07B 16.86B 15.37B 28.98B 1,955B 29.25B 204B 79.07B 999B 76.34B 74.68B 3,207B P/E 2027 *
22.5x
P/E 2028 * 19.9x
Enterprise Value 21.69B 19.27B 17.99B 16.39B 30.92B 2,085B 31.21B 218B 84.34B 1,066B 81.43B 79.66B 3,421B EV / Sales 2027 *
3.4x
EV / Sales 2028 * 3.15x
Free-Float
99.69%
Yield 2027 *
1.28%
Yield 2028 * 1.38%
Manager TitleAgeSince
Chief Executive Officer 53 2021-07-28
Director of Finance/CFO 59 2025-08-17
Compliance Officer - 2019-07-31
Director TitleAgeSince
Director/Board Member 73 2005-02-28
Director/Board Member 54 2018-04-30
Chairman 67 2018-07-27
Change 5-day change 1-year change 3-year change Capi.($)
+0.96%+3.19% - - 20.33B
+0.84%-3.74%-27.56%+1.93% 169B
-0.07%-2.55%-11.59%+13.26% 110B
+0.90%+1.13%-25.66%+3.47% 106B
-1.24%-0.76%-49.50%-12.46% 73.87B
-0.24%+0.69%+2.08%+69.19% 58.98B
+1.24%+3.69%+8.40%+61.61% 51.28B
-0.71%-3.82%-8.68%-31.93% 48.16B
+0.12%-0.17%-17.87%+19.66% 40.84B
-1.01%-1.45%+27.31%-2.67% 32.21B
Average +0.07%-0.86%-11.45%+13.56% 76.69B
Weighted average by Cap. +0.20%-1.30%-17.40%+11.09%

Financials

2027 *2028 *
Net sales 6.37B 5.66B 5.28B 4.82B 9.08B 613B 9.17B 63.95B 24.78B 313B 23.92B 23.41B 1,005B 6.78B 6.02B 5.62B 5.12B 9.66B 652B 9.75B 68.02B 26.36B 333B 25.45B 24.89B 1,069B
Net income 889M 790M 737M 672M 1.27B 85.44B 1.28B 8.92B 3.46B 43.68B 3.34B 3.26B 140B 1.02B 906M 845M 770M 1.45B 97.97B 1.47B 10.23B 3.96B 50.08B 3.83B 3.74B 161B
Net Debt 1.36B 1.2B 1.12B 1.03B 1.93B 130B 1.95B 13.61B 5.27B 66.65B 5.09B 4.98B 214B 1.02B 907M 847M 772M 1.46B 98.16B 1.47B 10.25B 3.97B 50.18B 3.83B 3.75B 161B
Logo Steris PLC
STERIS plc is one of the world's leading suppliers of sterilisation solutions and medical equipment. Net sales by business area break down as follows: - sale of sterilisation solutions and surgical equipment (70.9%): primarily cleaning products, accessories for gastrointestinal surgery, washers, sterilisers, surgical tables, lighting systems, etc. In addition, the group offers equipment repair and maintenance services; - development of sterilisation solutions (19.2%): sterilisation services, laboratory testing, and product and packaging testing for manufacturers of medical devices and pharmaceutical products; - sales of consumables and equipment (9.9%): for biopharmaceutical companies and manufacturers of medical devices. Net sales by source of income break down into sales of equipment (51.5%) and services (48.5%). Net sales are distributed geographically as follows: Ireland (1.8%), the United States (73%) and other (25.2%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-